Results strongly suggest the ERα-coupled Bmi1 regulatory pathway may be one of the main regulatory mechanisms in breast cancer, whose activity determines the down-stream gene status of p16INK4a and cyclin D1, and consequently impacts the biologic behavior of breast cancer. The gene discussed is CCND1; the disease is breast carcinoma.